title: [Properties and clinical application of quasi-liquid form of lysozyme].
abstract: The course of transendoscopic quasi-liquid form of lysozyme treatment of the relapse of peptic ulcer was microbiologically and clinically substantiated. A high antimicrobial and sorption activity of the quasi-liquid form of lysozyme with respect to the microflora isolated from the mucous membrane of the stomach and the duodenum was shown. The transendoscopic introduction of this form of lysozyme significantly reduces the time of the cicatrization of ulcers and the stay of patients in the hospital.
authors.affiliation: State Medical Academy, Tver, Russia.
authors.forename: E V
authors.initials: EV
authors.lastname: Strelets
authors.forename: E N
authors.initials: EN
authors.lastname: Egorova
authors.forename: V V
authors.initials: VV
authors.lastname: Chernin
authors.forename: V M
authors.initials: VM
authors.lastname: Chervinets
authors.forename: S N
authors.initials: SN
authors.lastname: Bazlov
mesh_terms: D000042:Absorption; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004304:Dosage Forms; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007455:Iodine; D009113:Muramidase / Q000008:administration & dosage / Q000494:pharmacology*; D010437:Peptic Ulcer / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D004304:Dosage Forms; D007455:Iodine; D009113:Muramidase